Novartis AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0QLR.IL | RHO.DE | AZN | GLAXO.NS | SANOFI.BO | BAYN.F | |
|---|---|---|---|---|---|---|
| Market cap | 306.88B | 348.82B | 293.14B | 423.55B | 77.83B | 54.43B |
| P/E (TTM) | 41.7 | 26.4 | 26.7 | 36.9 | 21.4 | — |
| Forward P/E | — | — | 16.7 | 31.6 | 19.0 | 11.4 |
| Price/book | 5.3 | 9.9 | 5.7 | 22.5 | 9.4 | 1.8 |
| Dividend yield | 3.78% | 2.50% | 1.69% | 2.25% | 3.56% | 0.21% |
| 1-year change | +31.45% | +47.21% | +12.81% | −2.83% | −27.27% | +105.27% |
| Today | +0.91% | 0.00% | +2.79% | −1.25% | +0.11% | +2.25% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All 0QLR.IL news ›Novartis heart drug failure leaves doctors seeking evidence for genetic cholesterol target
pharma.economictimes.indiatimes.com
Stock Market Today: Dow Jones, S&P 500, Nasdaq 10 Futures Gain as Fed Begins Its Two-Day Meet— Novartis, HSBC, Welltower in Focus (UPDATED)
Editor’s Note: The ETFs tracking benchmark indices, lede, economic data, and the headline were updated in the story. U.S. stock futures pared losses to advance Tuesday, as the Dow Jones, S&P 500, and Nasdaq 100 indices rose, following…
49ers TE George Kittle Teams Up With Novartis For Prostate Cancer Awareness
San Francisco 49ers tight end George Kittle has teamed up with Novartis, the NFL's first-ever pharmaceutical partner, to raise awareness of prostate cancer and encourage men to take action through blood-test screening. "My family…
Novartis: Q3 2026 Earnings Confirm 'Hold' Recommendation Based On Balanced Approach
Novartis is rated Hold, with a 12-month price target of $141.81, implying a 12.0% downside from the current share price. Read more on NVS stock here. - Novartis is rated Hold, with a 12-month price target of $141.81, implying a 12.0%…
Novartis books $2.2 billion hit from drug trial setbacks, but lifts guidance
ZURICH/LONDON, Oct 27 — Novartis recorded about $2.2 billion in charges related to two drugs that failed in late-stage studies last month, even as it boosted its full-year profit expectations on Tuesday. The Swiss drugmaker's operating…
More from 1 other outlet
Novartis Q3 Profit Sinks 70% Despite Sales Growth; Lifts FY26 Core Income View, Backs Sales Outlook
Novartis AG (NVS) reported Tuesday a sharp decline in third-quarter profit, reflecting an impairment charge and higher interest expense, despite increased sales. The Swiss drugmaker raised its full-year core operating income guidance and…
Alopecia Areata Pipeline 2026: Inside the Clinical Trial Landscape, Therapeutic Assessment, and Key Companies Involved | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte, Novartis
Alopecia Areata Pipeline 2026: Inside the Clinical Trial openPR.com Alopecia Areata Pipeline 2026: Inside the Clinical Trial Landscape, Therapeutic Assessment, and Key Companies Involved | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly…
Novartis Cosentyx® receives FDA approval for the treatment of children and adolescents with enthesitis-related arthritis and psoriatic arthritis
Every day, we work to reimagine medicine to improve and extend people’s lives. Learn about us and our story. Visit our resource hub for information around clinical trials, our products and innovation pipeline. Learn about our commitment to…
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe.…
More from 1 other outlet
Novartis cut to Sell at Deutsche Bank in Q3 review
Novartis (NVS) stock was downgraded to Sell from Hold at Deutsche Bank after the Swiss drugmaker showed a mixed performance with its Q3 2026 results. Read more here. Deutsche Bank downgraded Novartis (NVS) (NVSEF) to Sell from Hold on…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com36
- seekingalpha.com8
- novartis.com6
- tradingview.com5
- openpr.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 95 articles, not a forecast.